Adria Dangla-Valls
Overview
Explore the profile of Adria Dangla-Valls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foster E, Fernandes M, Dangla-Valls A, Hublitz P, Pangalos M, Lovestone S, et al.
Sci Rep
. 2022 Nov;
12(1):18639.
PMID: 36329114
Clusterin (CLU) is one of the most significant genetic risk factors for late onset Alzheimer's disease (AD). However, the mechanisms by which CLU contributes to AD development and pathogenesis remain...
2.
Foster E, Dangla-Valls A, Lovestone S, Ribe E, Buckley N
Front Neurosci
. 2019 Mar;
13:164.
PMID: 30872998
Clusterin (CLU) or APOJ is a multifunctional glycoprotein that has been implicated in several physiological and pathological states, including Alzheimer's disease (AD). With a prominent extracellular chaperone function, additional roles...
3.
Robbins J, Perfect L, Ribe E, Maresca M, Dangla-Valls A, Foster E, et al.
Front Neurosci
. 2018 Aug;
12:504.
PMID: 30090055
Our understanding of the molecular processes underlying Alzheimer's disease (AD) is still limited, hindering the development of effective treatments, and highlighting the need for human-specific models. Advances in identifying components...
4.
Dangla-Valls A, Molinuevo J, Altirriba J, Sanchez-Valle R, Alcolea D, Fortea J, et al.
Mol Neurobiol
. 2016 Oct;
54(9):6647-6654.
PMID: 27738874
MicroRNAs (miRNAs) are short non-coding RNA molecules that regulate gene expression through post-transcriptional repression of target genes. They have been shown to be implicated in the pathophysiology of Alzheimer's disease...
5.
Antonell A, Llado A, Sanchez-Valle R, Sanfeliu C, Casserras T, Rami L, et al.
Mol Neurobiol
. 2015 Oct;
53(9):5902-5911.
PMID: 26510741
Alzheimer's disease (AD) is the most common of the neurodegenerative diseases. Recent diagnostic criteria have defined a preclinical disease phase during which neuropathological substrates are thought to be present in...